REMEDY Stock Overview
Remedy Entertainment Oyj develops and sells console and computer games in Finland and internationally.
Remedy Entertainment Oyj Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€37.40|
|52 Week High||€49.90|
|52 Week Low||€31.20|
|1 Month Change||-11.58%|
|3 Month Change||-10.95%|
|1 Year Change||10.00%|
|3 Year Change||434.29%|
|5 Year Change||n/a|
|Change since IPO||459.04%|
Recent News & Updates
Do Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Warrant Your Attention?
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Estimating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)
Today we will run through one way of estimating the intrinsic value of Remedy Entertainment Oyj ( HEL:REMEDY ) by...
|REMEDY||FI Entertainment||FI Market|
Return vs Industry: REMEDY exceeded the Finnish Entertainment industry which returned -14.6% over the past year.
Return vs Market: REMEDY exceeded the Finnish Market which returned 11% over the past year.
|REMEDY Average Weekly Movement||5.0%|
|Entertainment Industry Average Movement||6.3%|
|Market Average Movement||4.6%|
|10% most volatile stocks in FI Market||6.8%|
|10% least volatile stocks in FI Market||3.0%|
Stable Share Price: REMEDY is not significantly more volatile than the rest of Finnish stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: REMEDY's weekly volatility (5%) has been stable over the past year.
About the Company
Remedy Entertainment Oyj develops and sells console and computer games in Finland and internationally. It primarily creates cinematic action games. The company was incorporated in 1995 and is based in Espoo, Finland.
Remedy Entertainment Oyj Fundamentals Summary
|REMEDY fundamental statistics|
Is REMEDY overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|REMEDY income statement (TTM)|
|Cost of Revenue||€6.52m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.71|
|Net Profit Margin||19.45%|
How did REMEDY perform over the long term?See historical performance and comparison
0.4%Current Dividend Yield
Is Remedy Entertainment Oyj undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: REMEDY (€37.8) is trading below our estimate of fair value (€54.58)
Significantly Below Fair Value: REMEDY is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: REMEDY is poor value based on its PE Ratio (53x) compared to the European Entertainment industry average (23.4x).
PE vs Market: REMEDY is poor value based on its PE Ratio (53x) compared to the Finnish market (22.7x).
Price to Earnings Growth Ratio
PEG Ratio: REMEDY is poor value based on its PEG Ratio (2x)
Price to Book Ratio
PB vs Industry: REMEDY is overvalued based on its PB Ratio (6.6x) compared to the XE Entertainment industry average (3.5x).
How is Remedy Entertainment Oyj forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: REMEDY's forecast earnings growth (26.3% per year) is above the savings rate (0.2%).
Earnings vs Market: REMEDY's earnings (26.3% per year) are forecast to grow faster than the Finnish market (3.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: REMEDY's revenue (17.4% per year) is forecast to grow faster than the Finnish market (3.6% per year).
High Growth Revenue: REMEDY's revenue (17.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if REMEDY's Return on Equity is forecast to be high in 3 years time
How has Remedy Entertainment Oyj performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: REMEDY has a high level of non-cash earnings.
Growing Profit Margin: REMEDY's current net profit margins (19.4%) are higher than last year (17.3%).
Past Earnings Growth Analysis
Earnings Trend: REMEDY's earnings have grown significantly by 49.7% per year over the past 5 years.
Accelerating Growth: REMEDY's earnings growth over the past year (44.4%) is below its 5-year average (49.7% per year).
Earnings vs Industry: REMEDY earnings growth over the past year (44.4%) exceeded the Entertainment industry 32.4%.
Return on Equity
High ROE: REMEDY's Return on Equity (12.4%) is considered low.
How is Remedy Entertainment Oyj's financial position?
Financial Position Analysis
Short Term Liabilities: REMEDY's short term assets (€75.2M) exceed its short term liabilities (€9.8M).
Long Term Liabilities: REMEDY's short term assets (€75.2M) exceed its long term liabilities (€2.8M).
Debt to Equity History and Analysis
Debt Level: REMEDY has more cash than its total debt.
Reducing Debt: REMEDY's debt to equity ratio has increased from 1.8% to 4.8% over the past 5 years.
Debt Coverage: REMEDY's debt is well covered by operating cash flow (372%).
Interest Coverage: REMEDY's interest payments on its debt are well covered by EBIT (9.6x coverage).
What is Remedy Entertainment Oyj current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: REMEDY's dividend (0.4%) isn’t notable compared to the bottom 25% of dividend payers in the Finnish market (1.7%).
High Dividend: REMEDY's dividend (0.4%) is low compared to the top 25% of dividend payers in the Finnish market (3.73%).
Stability and Growth of Payments
Stable Dividend: REMEDY is not paying a notable dividend for the Finnish market, therefore no need to check if payments are stable.
Growing Dividend: REMEDY is not paying a notable dividend for the Finnish market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: REMEDY is not paying a notable dividend for the Finnish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of REMEDY's dividend in 3 years as they are not forecast to pay a notable one for the Finnish market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Tero Virtala (47 yo)
Mr. Tero Virtala has been Chief Executive Officer at Remedy Entertainment Oyj since 2016. Mr. Virtala served as the Chief Executive Officer and Managing Director of Redlynx, Ltd. He serves as a Director of...
Experienced Management: REMEDY's management team is seasoned and experienced (5.9 years average tenure).
Experienced Board: REMEDY's board of directors are considered experienced (5.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.
Remedy Entertainment Oyj's employee growth, exchange listings and data sources
- Name: Remedy Entertainment Oyj
- Ticker: REMEDY
- Exchange: HLSE
- Founded: 1995
- Industry: Interactive Home Entertainment
- Sector: Media
- Market Cap: €497.362m
- Shares outstanding: 13.30m
- Website: https://www.remedygames.com
Number of Employees
- Remedy Entertainment Oyj
- Luomanportti 3
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/12/07 23:07|
|End of Day Share Price||2021/12/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.